Clinical tools for successful treatment of onychomycosis: a narrative review

被引:2
作者
Hassan, Nazia [1 ]
Dhamija, Piyush [1 ]
Bharti, Vishal [1 ]
Vishwakarma, Sneha [1 ]
Mansoor, Sheikh [2 ]
Iqbal, Zeenat [1 ]
机构
[1] Jamia Hamdard, Dept Pharmaceut, Sch Pharmaceut Educ & Res, New Delhi 110062, India
[2] SKUAST, Fac Basic Sci, Div Biochem, Jammu 180009, India
关键词
ND-YAG LASER; WHITE SUPERFICIAL ONYCHOMYCOSIS; TRICHOPHYTON-RUBRUM; PHOTODYNAMIC THERAPY; NDYAG LASER; DIAGNOSIS; TERBINAFINE; DESIGN; TRIAL;
D O I
10.1007/s40267-020-00722-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Onychomycosis is a difficult-to-treat fungal infection of the human nail plate or bed that primarily affects the natural anatomy of human toe and finger nails, leading to a hard, brittle, and uneven nail surface. The severe structural mutilation of nails restricts the application of conventional formulations and makes onychomycosis therapy a challenging clinical premise. Oral therapy with drugs such as terbinafine hydrochloride and itraconazole may lead to drug interactions and systemic adverse effects, whereas topical treatment with drugs such as ciclopirox olamine and amorolfine are often associated with poor drug permeation through the nail bed. Recent advances in laser/photodynamic therapies and their application in onychomycosis has emerged as a new therapeutic paradigm with global acceptance. The present article is an attempt to provide an insight into onychomycosis and its manifestations, and summarises the various therapeutic modalities, with a greater focus on laser/photodynamic therapy.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 53 条
[11]   A comparative clinical and mycological study of Nd-YAG laser versus topical terbinafine in the treatment of onychomycosis [J].
El-Tatawy, Rania A. ;
Abd El-Naby, Naeim M. ;
El-Hawary, Esraa E. ;
Talaat, Raghda A. Z. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (05) :461-464
[12]   Onychomycosis: Pathogenesis, diagnosis, and management [J].
Elewski, BE .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (03) :415-+
[13]   Causative pathogens in onychomycosis and the possibility of treatment resistance: A review [J].
Evans, EGV .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (05) :S32-S36
[14]   Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis [J].
Figueiredo Souza, L. W. ;
Souza, S. V. T. ;
Botelho, A. C. C. .
DERMATOLOGIC THERAPY, 2014, 27 (01) :43-47
[15]  
Firoz S, 2011, INT J INNOV DRUG DIS, V1, P9
[16]  
Gupta A, 2012, Skin Therapy Lett, V17, P4
[17]  
Gupta A K, 2005, Skin Therapy Lett, V10, P1
[18]   Safety of oral terbinafine - Results of a postmarketing surveillance study in 25884 patients [J].
Hall, M ;
Monka, C ;
Krupp, P ;
OSullivan, D .
ARCHIVES OF DERMATOLOGY, 1997, 133 (10) :1213-1219
[19]   Design, development and optimization of a transungual duple nail lacquer for onychomycosis therapy [J].
Hasan, N. ;
Singh, M. ;
Sulaiman, S. ;
Nandy, S. ;
Dudeja, M. ;
Ali, A. ;
Iqbal, Z. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (06) :E250-E251
[20]   Molecular Docking-Guided Ungual Drug-Delivery Design for Amelioration of Onychomycosis [J].
Hassan, Nazia ;
Singh, Manvi ;
Sulaiman, Sufiyanu ;
Jain, Pooja ;
Sharma, Kalicharan ;
Nandy, Shyamasree ;
Dudeja, Mridu ;
Ali, Asgar ;
Iqbal, Zeenat .
ACS OMEGA, 2019, 4 (05) :9583-9592